Profiles for drugs starting with 'o'
✉ Email this page to a colleague
US Patents and Regulatory Information for o
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ascent Pharms Inc | OXYCODONE AND ACETAMINOPHEN | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 207419-002 | Mar 22, 2017 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Pharmacia And Upjohn | ORINASE DIAGNOSTIC | tolbutamide sodium | INJECTABLE;INJECTION | 012095-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ipsen | ONIVYDE | irinotecan hydrochloride | INJECTABLE, LIPOSOMAL;INTRAVENOUS | 207793-001 | Oct 22, 2015 | RX | Yes | Yes | 12,364,691 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aucta | OXCARBAZEPINE | oxcarbazepine | SUSPENSION;ORAL | 215332-001 | Nov 30, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Abbvie | OMNICEF | cefdinir | CAPSULE;ORAL | 050739-001 | Dec 4, 1997 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Fresenius Kabi Usa | OXALIPLATIN | oxaliplatin | INJECTABLE;INTRAVENOUS | 078811-001 | Jun 10, 2010 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
